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Six chloroform/mcthanol-solubl¢ proteins from oat endosperm (Avena saliva) have been isolated and characterized bya purification procedure 
based on extraction with volatile solvents, followed by reversed-phase high performan~ liquid chromatography. Three of these proteins, with an 
assessed mol~ular weight of 25,000, 27,000 and 32,000 Da, respectively, have been identified by immunoblotting using ¢oeliac sere, as the major 
co¢liac serum leA-binding components ofoat endosperm. The N-terminal amino acid sequence of these proteins indicates that they correspond 
to oh., 74, and 7a avenins, respectively. We have tentatively named them 'coeliac immunoreactive proteins'. Another chloroform/methanol oat
component shows weak g-amylase inhibitory activity and exhibits trong homology (60% identity) at the N-tgrmin~ with the g-amylase inhibitor 
from ragi (Eleusilze coracana). 
Coelia¢ disease; Oat avenins; g.Amylase 
I. INTRODUCTION 
Cereal proteins are of increasing clinical interest be- 
cause they are involved in allergic processes [1-3] and 
intestinal disorders, particularly in ¢oeliac disease [4,5]. 
Besides, cereal seeds contain protein inhibitors of 0~- 
amylases and proteases [6] which play a protective role 
against endogenous and exogenous hydrolytic activi- 
ties. Although the proteins involved in coeliac disease 
and some enzyme inhibitors from wheat, barley and rye 
have been characterized, nothing is known yet about 
their presence in oat. 
Coeliac disease (gluten-sensitive enteropathy) is char- 
acterized by a reaction of hypersensitivity of the small 
intestine in genetically susceptible individuals after the 
ingestion of  gluten proteins of either flour or meal from 
wheat, rye, barl¢y and possibly oat [7,8]. Recently some 
progress on the causative agents has been made, and the 
alcohol-soluble proteins of the gluten fraction, collec- 
tively known as prolamins, and termed hordeins (bar- 
ley), gliadins (wheat) and scoalins (rye) have been re- 
ported as being responsible for the toxicity known to 
cause coeliac disease symptoms [9-11]. However, the 
implication of oat prolamins (avenins) in coeliac disease 
is controversial, probably due to the lower proportion 
(10-20%) of these proteins in the kernel in comparison 
to that in the other cereal prolamins [12]. Besides, oat 
prolamins related to coeliac disease have not been idea- 
tiffed yet and consequently they could not have been 
used for clinical or in vitro tests. 
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In the present report we describe asimple and reliable 
chromatographic procedure for the fractionation and 
isolation of chloroform/methanol-soluble proteins from 
oat endosperm. This has allowed us to identify three 
major avenins, which react with coeliac sere and that we 
have tentatively called oat 'coeliac immunorcactive pro- 
teins', as well as one cz-amylase inhibitor from oat en- 
dosperm. As far as we know, this is the first report 
identil~ing prolamins with antigen activity towards IgA 
from coeliac sera, together with one ~-amylase inhibitor 
from oat endosperm. 
2. MATERIALS AND METHODS 
2.1. Extraction and purification 
Soluble proteins from a chloroform/methanol extract of oat en- 
dosperm (Avena satire) were obtained as in [13]. The dried residual 
was extracted with ammonium bicarbonate as also d~scribcd in [14]. 
The soluble and insoluble bicarbonate extracts were chromatographed 
by a reversed-phase high performance liquid chromatography 0gP- 
HPLC) system with a Nucleosil CA silica column (8 ~ 2:30 ram) and 
elated with gradients of acatonitrile containing 0.1% trilluoroacetic 
acid or by a size-exclusion HPLC ffstem with Superos¢ 6 and 12 (10 
× 300 mln) columns connected in series, and elutcd isocratically with 
0.1% trilluoroacetic a id at a now rate of 0.3 ml/min. Mini-slab SDS- 
PAGE and amino acid analyses were performed as previously de- 
scribed [14]. 
2.2. Sequence d termination 
The oat proteins were scqacngg~d as described in [15] in a Knauer 
Modular Liquid Phase Protein Sequencer Model 810 equipped on line 
with a Knauer PTH-amino acid analyzer. 
2.3. lmlnunoblotting 
Aqcr SDS-PA,.qE, pto~qns were blot~d to PVDF membranes (Ira- 
mobiles, Millipore) as basically d~cribed in [16]. Blottings were per- 
formed at 10 V for 30 rain at room temperature, t~singa Biometm Fast 
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Blot semi-dry dcetrophoretic transfer cell, The lmmobilon mem- 
branes were first incubated for 1 h in Tris-buffered saline (TBS) ¢nn- 
raining 0,S% bovine serum albumin and 0,5% Triton X-100 and then 
incubated overnight with a coeliac serum (1:4,000) or normal serum 
(1:4,000) in the above buffer. The membranes were incubated l'or 3 h 
with rabbit anti-human alkaline plaosphatase-eonjugated [g-A 
(1:8,000}, For development of the color reaction, the membrane was 
incubated with 5-bromo-4-ehloro-3-indolyl phosphate p-toluidine salt 
and p-nitro blue tetrazolium chloride. 
2,4. cx.Amylase assay 
The activity of g-amylase was determined by using the Bernl'eld 
method [17]. g-Amylase (Type I-A) l'rom porcine pancreas an,.i the 
wheat g-amylase inhibitor (Type I) were purchased from Sigma Chem, 
Co, A probable ~-amylase inhibitor from barley endosperm (Hord,,um 
vu?gare) was prepared from a NaCl-soluble protein extract, followed 
by extraction with ammonium bicarbonate and RP-HPLC as above. 
3. RESULTS AND DISCUSSION 
In order to isolate and to identify oat proteins impli- 
cated in coeliac disease, the chloroform/methanol pro- 
tein extract from oat endosperm was fractionated with 
ammonium bicarbonate and the resulting soluble and 
insoluble fractions were analyzed by SDS-PAGE and 
immunoblotted using coeliac and normal sera (Fig. 1). 
Strong reaction with eoeliac serum was associated to the 
bicarbonate insoluble proteins, and no reaction was 
found in the bicarbonate soluble fraction (Fig. 1, cen- 
ter). This coeliac serum was tested against the corre- 
sponding bicarbonate insoluble proteins from wheat, 
barley and rye, and gave similar intensity bands to the 
oat fraction (data not shown). Similar resuits were also 
obtained with a total of ten coeliae sere (data not 
shown). 
To identify these oat-reactive proteins, the bicarbon- 
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Fig, 1. SDS-PAGE and immunoblotting analysis of the supernatant 
(S) and pellet (P) bicarbonate fractions from the total CM extract (*) 
from oat endosperm. Left: SDS-acrylamide g ls stained with Coomas- 
sic blue, Center and Right are the correspondin~ immunoblotting onto 
PVDF membranes, incubated with eoeliae and normal ser.m, respec- 
tively, and visualized by developing with anti-human lea  labeled with 
alkaline phosphatase. 
ate insoluble fraction was chromatographed by size- 
exclusioh HPLC. As shown in Fig. 2A, only peak l' was 
homogeneous when analyzed by SDS-PAGE. Peaks 1 
and 2 were reehromatographed by RP-HPLC while 
peak 3 was rechromatographed by the same size-exclu- 
sion system as above, and a total of eleven pure proteins 
showing a single band on SDS-PAGE were obtained 
(Fig. 2). 
The amino acid composition of all purified compo- 
nents reveals a high glutamie/glutamine (40%) and pro- 
line (10%) content which is the characteristic composi- 
tion of oat prolamins [18]. Based on amino acid compo- 
sition (data not shown), elcctrophoretic mobilities in 
SDS-PAGE, and sequence data, we have tentatively 
classified the eleven pure, components (la, 1 b, lc, 1', 2a, 
2b, 3a, 3b, 3c, 3d and 3e), in three different groups, 
called 1, 2 and 3 with respective molecular weights of 
27,000, 32,000 and 25,000 Da (Fig. 2). The NH2-termi- 
hal sequence of proteins 1, 2 and 3 fully coincided with 
the r4, Y3 and a~ avenins reported from oat [18] (Fig. 3) 
and do not exhibit significant sequence homology with 
other known prolamins from oat [19], as well as from 
wheat, barley and rye [18]. It is of interest hat proteins 
1, 2 and 3 migrate as several peaks on the same re- 
versed-phase chromatogra:la (Fig. 2B-D). In addition, 
protein 1 and 1' which present he same amino acid 
composition, N-terminal amino acid sequence and dec- 
trophoretic mobility in SDS-PAGE in the presence or 
in the absence of 2-mercaptoethanol, migrate as two 
peaks in a size-exclusion column (Fig. 2A). This chro- 
matographic behavior, could be due to denatured and 
native forms of avenins, as well as glutamine desamina- 
tions as it has been recently reported for other cereal 
proteins isolated by the same purification procedure 
[14]. 
Nevertheless, the possibility that some of these iso- 
lated avetfins, could represent heterogeneous compo- 
nents [18] due to (i) multigen families exhibiting a few 
amino acid substitutions in the two distinct tanden re- 
peat consensus sequences [19], (ii) gene duplications, or 
(iii) carbohydrate heterogeneity as described for gliad- 
ins [20], have yet to be investigated. In fact, proteins 
grouped as 1, 2 and 3 could simply be eleven isolated 
genetic variants of avenins with minor variations in the 
amino acid sequence and consequently migrating differ- 
ently in the RP-HPLC (Figs. 2 and 3). 
Antibody reactivity against hese purified oat avenins 
was investigated by immunoblotting, with a serum from 
a patient with coeliac disease (Fig. 2), as well as with ten 
different coeliac sere (data not shown). As can be seen, 
they all reacted strongly with cocliac serum in contrast 
to the negative reaction obtained with a normal serum, 
used as control (Fig. 2). According to these results the 
. . . . . . . . .  y of oat ,,, , , , , ,s 7,, . . . .  g2 .g  . . . .  S . . . . . . . .  
sere appears quite clear in the present study, despite 
uncertainties in the literature as to the specificity of oat 
avenins in coeliae disease [10]. As far as we know, this 
38 
Volume 310, number 1 FEBS LETTERS September 1992 
1.e l 'a  2a  A A B :~7:~,,., :.  ~.... ," 0.2 
, .~! . . . .~ . ' : .~ .  I I I~  ,~ .. 
• I u \ / - k  
o - / t  , - - - ' "7  s , 
°"*f / C 0.4 D, fi  
0 I- t~..~P--~ , ~----'~--" , 0 -/ 
O0 90 12o T IME (min) ~so 200 2~0 
kDa la  lb  lo  2a 2b 8a 8b  8c3d  30 
. . . .  ~ ~ Coomass ie  Blue  
21  ~ m,!  
• : . . , . . , - ,>, . . . . . ! . , -~:  
--'- - - , ,mq i ,  ~ Coe l lac  Serum 
. . ,  .= ..... 
: : :  ~ Normal  Serum 
Fig. 2, Fractionation f the bi~rbonate insoluble fraction from oat endosperm. (A) The bicarbonate-insoluble extract was resuspended in 0. I% 
TFA and injured into two conneeted in~ries Superose 6+ Superose 12 columns and eluted with 0.1% TFA. SDS-PAGE stained with Cooma~sie 
blue of the fractions indicated by bars is shown as an insert. (B) and (C) repurifieatinn of peaks 1 and 2 by RP-HPLC on a Nucleosil C4 column 
and eluted with a littear gradient of acetonitrile from 36 to 50% containing 0.1% TFA. (D) Purification ofpeak 3 by the same size-exclusion Supcro~ 
columns as (A). SDS.PAGE stained with Coomassie blue of the fractions indicated by bars, in B, C and D and the corresponding immunoblotting 
developed with coeliac serum or normal serum are shown at the bottom. The mobilities of the standard proteins are also indicated. 
is the first report on the identification of oat prolamins 
with immunoreactive properties with coeliac sera. We 
have tentatively designated them as oat 'coeliac im- 
munoreaetive proteins' (CIP) and we have called the 
three isolated reactive oat prolamins 1, 2 and 3 as Oat 
CPI-1, CPI-2 and CPI-3, respectively. 
Reversed-phase high performance liquid chromatog- 
raphy of the bicarbonate soluble fraction is shown in 
Fig. 4. Six components showing a single band around 
10,000 to 12,000 Da were isolated. The amino acid com- 
position of these proteins indicates that they do not 
belong to the prolamin class (data not shown) and they 
do not show any reaction to coeliac serum (data not 
shown). With the analytical criteria mentioned above 
the six proteins (A1, A2, BI, B2, CI and C2) were also 
found to consist of only three different groups, with 
respective molecular weights of 12,500, 11,000 and 
10,000 Da (Fig. 4) and we have de~isnated them as 
protein Oat-A, Oat-B and Oat-C, respectively. The N- 
te..rmina! sequence of Oat-A and Oat-C does not have 
any clear homology with other cereal components, but 
Oat-B shows a significant homology (60--88% of iden- 
tity) with the 0~-amylase inhibitor from ragi [6], as well 
as with the two probable ~-amylase inhibitors from rice 
[21] and barley [22] (Fig. 3). 
In order to characterize the possible function of Oat- 
B, o~-amylase assays were performed with the porcine 
pancreatic ~-amyla~. Oat-B showed a weak inhibition 
of this enzyme of porcine pancreas (32%) in comparison 
with the 70% inhibitory effect of the wheat (x-amylase 
oat OJP-1 (y4) 
Oat CIP-2 (~) 
On! CIP.3 (02) 
0111. A 
Oat. C 
Oal-B 
~I1W Pa.AI 
Rico Pa,AI 
Flagi o.Al 
IO 20 
[PSEQYQPY P I~QQQPF I  
Ff'f'c vHPs EQY QPj PEQoQ P IVQOQ ', e 
FTTVQYpIp@~QYQPI 
TSQXI~ YPYPSMGLPSF IXLYGXXR 
SVGDQXVPQW^I X ~'IPLQQ 
Fig. 3. N-terminal mino acid ~quen~ of the i~lated oat proteins. 
Common sequences are indicated in boxes. Oat-tiP-I, 2 and 3 corre- 
spond to the following known components: y,, ~,s and ~t2 avenins. 
respectively. Ragi 0~-amyla~ inhibitor (~-Ai) [6l and the probable ri~'= 
and barley ~-amyla~ inhibitors (Pot-AI) [21,22] have been included to 
be compared with the ahoy, avenins. Unidentified positions are indi- 
cated by X. Gaps are ~ncluded toachieve maximum homolog),. 
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FiB. 4. Fractionation by RP-HPLC of the bicarbonate soluble fraction 
from oat endosperm. The bicarbonate soluble extract in 0. I% TFA 
was injected into a Naeleosil C4 column and elated with a linear 
gradient of acetonitrile from 0 to 50% containing 0.1% TFA. SDS- 
PAGE of the fractions indicated by bars are inserted. The lane marked 
with an asterisk corresponds to the total soluble extract. The mobilities 
of the standard proteins am also indicated, 
inhibitor. No inhibitory effect was obtained with the 
probable ~-amylase inhibitor from barley used as con- 
trol (data not shown), which does not inhibit 0c-amylase 
activity [22]. This finding establishes for the first time 
the existence of proteins from oat endosperm with ~- 
amylase inhibitory activity. The existence in Oat-B of 
another inhibitory effect against an entirely unrelated 
enzyme Oat-B, as already described for other bifunc- 
tional cereal proteins (a-amylase/protease inhibitor) 
[21,22], has yet to be investigated. 
In summary, according to the present results, six 
chloroform/methanol proteins from oat endosperm, in- 
cluding three major coeliac immunoreactive proteins 
(previously described as ~., 73 and 74 avenins), and a 
new g-amylase inhibitor (Oat-B), have been identified 
and characterized. The characterization of these oat an- 
tigens could contribute to the understanding of some 
immunological aspects of coeliac disease and also to 
determine their possible harmful effects in clinical tests 
and in vitro tissue culture [23]. 
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